重组Anti-MLKL抗体[EPR17514]
Anti-MLKL antibody [EPR17514]
- RabMAb
- Recombinant
- KO Validated
- 20ul selling size
- 了解详情
5
(5 Reviews)
|
(126 Publications)
Anti-MLKL antibody [EPR17514] (ab184718) is a rabbit monoclonal antibody detecting MLKL in Western Blot, IHC-P, ICC/IF. Suitable for Human.
- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 80 publications
查看别名
Mixed lineage kinase domain-like protein, hMLKL, MLKL
- WB
Unknown
Western blot - Anti-MLKL antibody [EPR17514] (AB184718)
Lanes 1 - 4 : Merged signal (red and green). Green - ab184718 observed at 54 kDa. Red - loading control, ab8245 observed at 37 kDa.
ab184718 was shown to react with MLKL in wild-type HeLa cells. Loss of signal was observed when knockout cell line ab255408 (knockout cell lysate ab263788) was used. Wild-type and MLKL knockout samples were subjected to SDS-PAGE. ab184718 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-MLKL antibody [EPR17514] (ab184718) at 1/1000 dilution
Lane 1:
HUVEC cell lysate at 20 µg
Lane 2:
HT-29 cell lysate at 20 µg
Lane 2:
Western blot - Human MLKL knockout HeLa cell line (<a href='/products/cell-lines/human-mlkl-knockout-hela-cell-line-ab255408'>ab255408</a>)
Lane 3:
Wild-type HeLa cell lysate at 20 µg
Lane 4:
MLKL knockout HeLa cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/20000 dilution
Predicted band size: 54 kDa
Observed band size: 37 kDa,54 kDa
false
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MLKL antibody [EPR17514] (AB184718)
Immunohistochemical analysis of paraffin-embedded Human tonsil tissue labeling MLKL with ab184718 at 1/400 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) secondary antibody (ab97051) at 1/500 dilution. Cytoplasmic staining on the lymphocytes of human tonsil is observed. Counter stained with Hematoxylin.
Negative control : Using PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-MLKL antibody [EPR17514] (AB184718)
ab184718 staining MLKL in HT-29 (Human colorectal adenocarcinoma epithelial cell) cells by Immunocytochemistry (ICC). Cells were fixed with 100% Methanol. Samples were incubated with primary antibody at 1/200 dilution (6.5μg/ml). An AlexaFluor® 488 Goat anti-Rabbit (ab150077) was used as the secondary antibody at 1/1000 dilution (2μg/ml). ab195889 , Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) was used as the counterstain antibody (1/200 dilution, 2.5 μg/ml . DAPI was used as a nuclear counterstain. Confocal image showing cytoplasmic staining on HT-29 cell line.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MLKL antibody [EPR17514] (AB184718)
Immunohistochemical analysis of paraffin-embedded Human colonic adenocarcinoma tissue labeling MLKL with ab184718 at 1/400 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) secondary antibody (ab97051) at 1/500 dilution. Cytoplasmic staining on tumor cells of human colonic adenocarcinoma is observed. Counter stained with Hematoxylin.
Negative control : Using PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- WB
Lab
Western blot - Anti-MLKL antibody [EPR17514] (AB184718)
Lanes 1 - 4 : Merged signal (red and green). Green - ab184718 observed at 55 kDa. Red - loading control, ab8245, observed at 37 kDa.
ab184718 was shown to recognize MLKL in wild-type HAP1 cells along with additional cross-reactive bands. No band was observed when MLKL knockout samples were examined. Wild-type and MLKL knockout samples were subjected to SDS-PAGE. ab184718 and ab8245 (loading control to GAPDH) were diluted to 1/1000 and 1/2000 respectively and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1/10,000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-MLKL antibody [EPR17514] (ab184718) at 1/1000 dilution
Lane 1:
Wild-type HAP1 cell lysate at 20 µg
Lane 2:
MLKL knockout HAP1 cell lysate at 20 µg
Lane 3:
HeLa cell lysate at 20 µg
Lane 4:
Huvec cell lysate at 20 µg
Predicted band size: 54 kDa
false
- WB
Supplier Data
Western blot - Anti-MLKL antibody [EPR17514] (AB184718)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-MLKL antibody [EPR17514] (ab184718) at 1/20000 dilution
Lane 1:
HUVEC (Human umbilical vein endothelial cell line) whole cell lysate at 20 µg
Lane 2:
HT-29 (Human colorectal adenocarcinoma cells) whole cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L),Peroxidase conjugated at 1/1000 dilution
Predicted band size: 54 kDa
false
- WB
Supplier Data
Western blot - Anti-MLKL antibody [EPR17514] (AB184718)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-MLKL antibody [EPR17514] (ab184718) at 1/1000 dilution
All lanes:
Human fetal kidney lysate at 10 µg
Secondary
All lanes:
Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/1000 dilution
Predicted band size: 193 kDa,37 kDa,45 kDa,52 kDa,54 kDa,98 kDa
Observed band size: 115 kDa,193 kDa,35 kDa,37 kDa,45 kDa,52 kDa,54 kDa
false
不同偶联物与剂型 (4)
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-MLKL antibody [EPR17514]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-MLKL antibody [EPR17514]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-MLKL antibody [EPR17514]
-
Anti-MLKL antibody [EPR17514] - BSA and Azide free
反应性数据
产品详情
Product Specifications
Anti-MLKL antibody [EPR17514] (ab184718) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in ICC/IF, IHC-P, WB in human samples.
Anti-MLKL antibody [EPR17514] (ab184718) specifically detects MLKL (UniProt ID: Q8NB16; Molecular weight: 54kDa) and is sold in 100 µL and 1 mL selling sizes.
Quality and Validation
Abcam's high quality manufacturing and validation processes ensure Anti-MLKL antibody [EPR17514] (ab184718) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility.
The specificity of Anti-MLKL antibody [EPR17514] (ab184718) has been confirmed by testing in knockout samples.
Anti-MLKL antibody [EPR17514] (ab184718) has been cited over 84 times in peer reviewed journals and is trusted by the scientific community.
Anti-MLKL antibody [EPR17514] (ab184718) has 5 independent reviews from customers.
Related Products
Conjugation-ready, carrier free format available for antibody clone EPR17514 - ab211045.
Antibody clone EPR17514 is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor® 488, Alexa Fluor® 647, Alexa Fluor® 594 (ab207901, ab207902, ab208082).
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
性能和储存信息
形式
纯化工艺
存储溶液
运输条件
推荐的短期储存时间
推荐的短期储存条件
推荐的长期储存条件
分装信息
储存信息
补充信息
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The MLKL protein acts as an executioner of cell death by forming a complex that disrupts the plasma membrane integrity. This process is downstream of receptor-interacting serine/threonine-protein kinase 3 (RIPK3) which phosphorylates MLKL to form the active necrosome complex. Active MLKL oligomerizes and migrates towards the inner leaflet of the plasma membrane binding to phosphatidylinositol phosphates which assists in pore formation and cellular rupture. The ability to measure MLKL activity levels such as via MLKL ELISA kits is important for understanding necrotic processes in detailed studies.
Pathways
MLKL is integrally involved in the necroptotic pathway alongside RIPK1 and RIPK3 which are key initiators of necroptosis. Phosphorylated MLKL acts downstream of RIPK3 resulting in cell death without caspase activation distinguishing necroptosis from apoptosis. MLKL and RIPK3 are tightly linked within this pathway with MLKL phosphorylation serving as a vital event for the execution phase. The necroptosis pathway is part of larger networks including inflammatory response pathways highlighting the importance of MLKL's role beyond sheer cell death.
产品实验方案
- Visit the General protocols
- Visit the Troubleshooting
靶点信息
文献 (126)
Recent publications for all applications. Explore the full list and refine your search
Toxics 13: PubMed41012357
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell research 35:840-858 PubMed40940518
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell death discovery 11:413 PubMed40877228
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cell death 3: PubMed40809836
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular and molecular medicine 29:e70739 PubMed40771071
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell death discovery 11:345 PubMed40715038
2025
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 15:22592 PubMed40595878
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 16:456 PubMed40533460
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 16:4288 PubMed40341069
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 16:4128 PubMed40319089
2025
Applications
Unspecified application
Species
Unspecified reactive species
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com